- cafead May 28, 2024 at 11:22: AM
via This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. Series A commitments.
So far in 2024, biotech and health companies have pulled in around $5.6 billion across 110 Series A rounds, per Crunchbase data. That accounts for 53% of all funding at the Series A stage, which is a closely watched barometer for the startup ecosystem.
article source
So far in 2024, biotech and health companies have pulled in around $5.6 billion across 110 Series A rounds, per Crunchbase data. That accounts for 53% of all funding at the Series A stage, which is a closely watched barometer for the startup ecosystem.
article source